Major cannabis operators are emphasizing cash generation and operational discipline as the industry prepares for its next phase of growth. Verano reported improved quarterly results, Tilray expanded its beverage restructuring, and a federal-state conflict emerged over whether medical cannabis should ever move through the U.S. mail.
Verano Revenue Rises as Operating Cash Flow Reaches Four-Year High
Verano Holdings reported third-quarter revenue of $212.4 million, up 5% from a year earlier. The multistate operator recorded a $4.1 million net loss, compared with a $43.8 million loss in the prior-year quarter, while net cash from operating activities increased to $49 million from $26 million.
Adjusted EBITDA declined to $50.4 million from $53.1 million despite the revenue gain. Verano also raised its 2026 capital-expenditure guidance to between $54 million and $60 million after expanding its Florida retail network and entering the cannabis beverage category.
Why It Matters: Analysis: Verano’s higher revenue, narrower loss and stronger cash generation offer a healthier operating signal than top-line growth alone. The lower adjusted EBITDA and increased capital budget nevertheless show that expansion, pricing pressure and operating costs remain important tests for the business.
Source: Verano Holdings
Tilray Targets $20 Million in Beverage Savings After Brewery Consolidation
Tilray Brands said it has reduced its U.S. brewing footprint from 10 facilities to six and is pursuing additional changes across manufacturing, warehousing, procurement, logistics and distribution. The company is targeting approximately $20 million in annualized savings by the end of fiscal 2028.
The restructuring is intended to improve utilization ahead of Tilray’s U.S. partnership with Carlsberg, scheduled to launch January 1, 2027. Tilray said the partnership is targeting one million cases during its first year and reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million.
Why It Matters: Analysis: Tilray’s beverage platform has become central to its strategy for building U.S. infrastructure and consumer distribution while federal cannabis opportunities remain constrained. Delivering the projected savings and Carlsberg volume without materially increasing fixed costs would strengthen the financial case for that diversification.
Source: Tilray Brands
Senators Press USPS to Keep Cannabis Out of the Mail
Republican Sens. James Lankford of Oklahoma and Ted Budd of North Carolina urged the U.S. Postal Service to maintain its prohibition on mailing marijuana. Their October 28 letter responds to Georgia’s move to authorize delivery of state-regulated medical cannabis through USPS and private carriers.
The senators argued that federal rescheduling should not make cannabis broadly mailable and asked USPS not to revise its regulations to accommodate the Georgia policy. The letter does not itself change postal rules or determine whether Georgia licensees will ultimately be able to use federal or private delivery networks.
Why It Matters: Analysis: The dispute illustrates how federal cannabis reform can create operational questions that rescheduling alone does not clearly resolve. A definitive USPS position could affect patient access, delivery economics and compliance models well beyond Georgia.
Source: Office of U.S. Senator James Lankford
What We’re Watching
Over the next 24 to 72 hours, watch for market reaction and additional disclosures following Verano’s earnings, further details on Tilray’s brewery and distributor consolidation, and any response from USPS or Georgia regulators concerning medical cannabis deliveries.
